Digene HPV Genotyping RH Test RUO: Comparative evaluation with INNO-LiPA HPV Genotyping Extra Test for detection of 18 high-risk and probable high-risk human papillomavirus genotypes

Journal of Clinical Virology

Volumn 46, Issue 2, 2009, Pages 176-179

  Seme, Katja ^a   Lepej, Snježana Židovec ^b   Lunar, Maja M ^a   Iščić Beš, Janja ^b   Planinić, Ana ^b   Kocjan, Boštjan J ^a   Vince, Adriana ^b   Poljak, Mario ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b Croatia   (Croatia)

Author keywords

Digene; Genotyping; HPV; INNO LiPA; Reverse hybridization

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; ASSAY; COMPARATIVE STUDY; FEMALE; GENOTYPE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ALPHAPAPILLOMAVIRUS; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; UTERINE CERVICAL DISEASES;

EID: 69449096929     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.07.017     Document Type: Article

References (19)

1. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 (2004) 17-27
2. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
3. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
4. Cuschieri K.S., and Cubie H.A. The role of human papillomavirus testing in cervical screening. J Clin Virol 32 Suppl. 1 (2005) S34-S42
5. Iftner T., and Villa L.L. Human papillomavirus technologies. J Natl Cancer Inst Monogr 31 (2003) 80-88
6. Smith R.A., Cokkinides V., and Eyre H.J. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 53 (2003) 27-43
7. Wright Jr. T.C., Cox J.T., Massad L.S., Twiggs L.B., Wilkinson E.J., ASCCP-Sponsored Consensus Conference, and 2002. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 287 (2001) 2120-2129
8. Solomon D., Schiffman M., Tarone R., and The ALTS Study Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 92 (2000) 397-402
9. Poljak M., Marin I.J., Seme K., and Vince A. Hybrid Capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high risk cocktail. J Clin Virol 25 (2002) S89-97
10. Castle P.E., Solomon D., Wheeler C.M., Gravitt P.E., Wacholder S., and Schiffman M. Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol 46 (2008) 2595-2604
11. van Hamont D., van Ham M.A., Bakkers J.M., Massuger L.F., and Melchers W.J. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J Clin Microbiol 449 (2006) 3122-3129
12. Feng Q., Cherne S., Winer R.L., Balasubramanian A., Lee S.K., Hawes S.E., et al. Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J Clin Microbiol 47 (2009) 547-553
13. Castle P.E., Solomon D., Schiffman M., and Wheeler C.M. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst 97 (2005) 1066-1071
14. Khan M.J., Castle P.E., Lorincz A.T., Wacholder S., Sherman M., Scott D.R., et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97 (2005) 1072-1079
15. Dalstein V., Merlin S., Bali C., Saunier M., Dachez R., and Ronsin C. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus. J Virol Methods 156 (2009) 77-83
16. Coutlée F., Rouleau D., Petignat P., Ghattas G., Kornegay J.R., Schlag P., et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol 44 (2006) 1998-2006
17. Tieben L.M., Schegget J., Minnaar R.P., Bouwes Bavinck J.N., Berkhout R.J., Vermeer R.J., et al. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J Virol Methods 42 (1993) 265-279
18. Kocjan B.J., Poljak M., Seme K., Potočnik M., Fujs K., and Babič D.Z. Distribution of human papillomavirus genotypes in plucked eyebrow hairs from Slovenian males with genital warts. Infect Genet Evol 5 (2005) 255-259
19. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 38 (2000) 357-361